acetazolamide has been researched along with Cerebrovascular Moyamoya Disease in 46 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We present the case of a 42-year-old man with moyamoya disease presenting for cerebral revascularization surgery who developed critical hyperkalemia following a single intravenous (iv) dose of 1000 mg of acetazolamide 1 day preoperatively for a cerebrovascular reactivity study." | 7.96 | Paradoxical Critical Hyperkalemia After Acetazolamide for Cerebrovascular Reactivity Study: A Case Report. ( Burbridge, MA; Jaffe, RA, 2020) |
| "We present the case of a 42-year-old man with moyamoya disease presenting for cerebral revascularization surgery who developed critical hyperkalemia following a single intravenous (iv) dose of 1000 mg of acetazolamide 1 day preoperatively for a cerebrovascular reactivity study." | 3.96 | Paradoxical Critical Hyperkalemia After Acetazolamide for Cerebrovascular Reactivity Study: A Case Report. ( Burbridge, MA; Jaffe, RA, 2020) |
| " The history of this patient with prolonged acidosis is analyzed, and the role of metabolic changes induced by H(2) 15O-PET with acetazolamide challenge is reviewed." | 3.72 | Metabolic changes after H(2) 15O-positron emission tomography with acetazolamide in a patient with moyamoya disease: case report and review of previous cases. ( Keller, E; Khan, N; Muroi, C; Pangalu, A; Yonekawa, Y, 2003) |
| "To elucidate the relationship between cerebral blood flow (CBF) after hyperventilation (HV) and the rebuild-up phenomenon on the encephaloelectrogram (EEG) in children with moyamoya disease, comparative study of CBF immediately after HV and CBF after administration of acetazolamide (Diamox) was examined." | 3.68 | [Cerebral blood flow reactivity to hyperventilation in children with spontaneous occlusion of the circle of willis (moyamoya disease)]. ( Abe, H; Isobe, M; Kamiyama, H; Kuroda, S; Mitumori, K, 1992) |
| "Transient ischemic attacks and cerebral infarction were the common symptoms in these patients." | 2.47 | Concurrent Graves' disease and intracranial arterial stenosis/occlusion: special considerations regarding the state of thyroid function, etiology, and treatment. ( Murakami, H; Nakagawa, T; Ohba, S, 2011) |
| "Pre-operative patients diagnosed with moyamoya disease who could undergo MRI at 3." | 1.46 | Cerebral blood flow, transit time, and apparent diffusion coefficient in moyamoya disease before and after acetazolamide. ( Christensen, S; Federau, C; Moseley, M; Ni, W; Park, SW; Zaharchuk, G; Zun, Z, 2017) |
| "Moyamoya disease is characterized by bilateral progressive terminal internal carotid arteries steno-occlusion." | 1.46 | Brain Perfusion Before and After Surgical Treatment of Moyamoya Disease. ( Boulahdour, H; Drouet, C; Morel, O; Porot, C; Thines, L, 2017) |
| "Young patients with moyamoya disease frequently exhibit extensive cerebral infarction at the time of initial presentation, and even in the early postoperative period." | 1.36 | Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion. ( Fujimura, M; Hayashi, T; Shirane, R; Tominaga, T, 2010) |
| "Sixteen adult patients with ischemic Moyamoya disease and 12 age-matched normal control subjects underwent both ACZ-challenged CT perfusion and digital subtraction angiography." | 1.35 | Quantitative cerebrovascular reserve measured by acetazolamide-challenged dynamic CT perfusion in ischemic adult Moyamoya disease: initial experience with angiographic correlation. ( Kang, KH; Kim, HS; Kim, SY, 2008) |
| "Limb shaking in Moyamoya disease may result from a transient hypoperfusion of the contralateral frontoparietal cortex rather than basal ganglia." | 1.32 | Hyperventilation-induced limb shaking TIA in Moyamoya disease. ( Chung, CS; Han, DH; Kim, HY; Lee, J; Lee, KH, 2003) |
| "Subsequently, cerebral infarction occurred in the corresponding area." | 1.29 | Cerebral vasodilatory capacity mapping using technetium-99m-DTPA-HSA SPECT and acetazolamide in moyamoya disease. ( Honda, N; Inoue, Y; Machida, K; Momose, T; Tsutsumi, K, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (30.43) | 18.2507 |
| 2000's | 8 (17.39) | 29.6817 |
| 2010's | 19 (41.30) | 24.3611 |
| 2020's | 5 (10.87) | 2.80 |
| Authors | Studies |
|---|---|
| Togao, O | 3 |
| Obara, M | 3 |
| Yamashita, K | 3 |
| Kikuchi, K | 3 |
| Arimura, K | 3 |
| Nishimura, A | 3 |
| Nakamizo, A | 3 |
| Wada, T | 3 |
| Tokunaga, C | 3 |
| Mikayama, R | 3 |
| Yamashita, Y | 3 |
| Hamano, H | 3 |
| Van Cauteren, M | 3 |
| Ishigami, K | 3 |
| Baba, S | 3 |
| Lewén, A | 1 |
| Fahlström, M | 1 |
| Borota, L | 1 |
| Larsson, EM | 1 |
| Wikström, J | 1 |
| Enblad, P | 1 |
| Roder, C | 1 |
| Haas, P | 1 |
| Fudali, M | 1 |
| Milian, M | 1 |
| Ernemann, U | 1 |
| Meyer, PT | 1 |
| Tatagiba, M | 1 |
| Khan, N | 4 |
| Burbridge, MA | 1 |
| Jaffe, RA | 1 |
| Deckers, PT | 1 |
| van Hoek, W | 1 |
| Kronenburg, A | 1 |
| Yaqub, M | 1 |
| Siero, JCW | 1 |
| Bhogal, AA | 1 |
| van Berckel, BNM | 1 |
| van der Zwan, A | 1 |
| Braun, KPJ | 1 |
| Mugikura, S | 1 |
| Fujimura, M | 2 |
| Takahashi, S | 2 |
| Takase, K | 1 |
| Chong, S | 1 |
| Park, JD | 1 |
| Chae, JH | 1 |
| Cheon, JE | 1 |
| Kim, SK | 2 |
| Phi, JH | 1 |
| Lee, JY | 1 |
| Paeng, JC | 1 |
| Wang, KC | 2 |
| Aboukais, R | 1 |
| Verbraeken, B | 1 |
| Leclerc, X | 1 |
| Gautier, C | 1 |
| Henon, H | 1 |
| Vermandel, M | 1 |
| Menovsky, T | 1 |
| Lejeune, JP | 1 |
| Cortés, J | 1 |
| Arias-Rivas, S | 1 |
| Rodriguez-Yañez, M | 1 |
| Blanco, M | 1 |
| Aguiar, P | 1 |
| Kim, SJ | 1 |
| Son, TO | 1 |
| Kim, KH | 1 |
| Jeon, P | 1 |
| Hyun, SH | 1 |
| Lee, KH | 2 |
| Yeon, JY | 1 |
| Kim, JS | 1 |
| Hong, SC | 1 |
| Shin, HJ | 1 |
| Bang, OY | 1 |
| Kuhn, FP | 1 |
| Warnock, G | 1 |
| Schweingruber, T | 1 |
| Sommerauer, M | 1 |
| Buck, A | 2 |
| Noguchi, T | 1 |
| Kawashima, M | 1 |
| Nishihara, M | 1 |
| Egashira, Y | 1 |
| Azama, S | 1 |
| Irie, H | 1 |
| Tanizaki, Y | 1 |
| Kimura, H | 1 |
| Akaji, K | 1 |
| Nakazawa, M | 1 |
| Yoshida, K | 2 |
| Mihara, B | 1 |
| Federau, C | 1 |
| Christensen, S | 1 |
| Zun, Z | 1 |
| Park, SW | 1 |
| Ni, W | 1 |
| Moseley, M | 1 |
| Zaharchuk, G | 1 |
| Drouet, C | 1 |
| Morel, O | 1 |
| Thines, L | 1 |
| Porot, C | 1 |
| Boulahdour, H | 1 |
| Rim, NJ | 1 |
| Kim, HS | 2 |
| Shin, YS | 1 |
| Kim, SY | 2 |
| Suyama, K | 1 |
| Hayashi, K | 1 |
| Takahata, H | 1 |
| Yonekura, M | 1 |
| Nagata, I | 2 |
| Andaluz, N | 1 |
| Choutka, O | 1 |
| Vagal, A | 1 |
| Strunk, R | 1 |
| Zuccarello, M | 1 |
| Calviere, L | 2 |
| Catalaa, I | 2 |
| Marlats, F | 2 |
| Viguier, A | 1 |
| Bonneville, F | 2 |
| Cognard, C | 1 |
| Larrue, V | 2 |
| Hayashi, T | 1 |
| Shirane, R | 1 |
| Tominaga, T | 1 |
| Ohba, S | 1 |
| Nakagawa, T | 1 |
| Murakami, H | 1 |
| Ideguchi, R | 1 |
| Morikawa, M | 1 |
| Enokizono, M | 1 |
| Ogawa, Y | 1 |
| Uetani, M | 1 |
| Ma, Y | 1 |
| Li, M | 1 |
| Jiao, LQ | 1 |
| Zhang, HQ | 1 |
| Ling, F | 1 |
| Ssi Yan Kai, G | 1 |
| Ogiwara, H | 1 |
| Morota, N | 1 |
| Murai, Y | 1 |
| Mizunari, T | 1 |
| Takagi, R | 1 |
| Amano, Y | 1 |
| Mizumura, S | 1 |
| Komaba, Y | 1 |
| Okubo, S | 1 |
| Kobayashi, S | 1 |
| Teramoto, A | 1 |
| Kim, HY | 1 |
| Chung, CS | 1 |
| Lee, J | 1 |
| Han, DH | 1 |
| Muroi, C | 1 |
| Yonekawa, Y | 1 |
| Pangalu, A | 1 |
| Keller, E | 1 |
| Weber, B | 1 |
| Westera, G | 1 |
| Treyer, V | 1 |
| Burger, C | 1 |
| So, Y | 1 |
| Lee, HY | 1 |
| Lee, JS | 1 |
| Cho, BK | 1 |
| Kang, E | 1 |
| Lee, DS | 1 |
| Kang, KH | 1 |
| Kuroda, S | 3 |
| Kamiyama, H | 3 |
| Isobe, M | 2 |
| Houkin, K | 2 |
| Abe, H | 3 |
| Mitsumori, K | 2 |
| Inoue, Y | 2 |
| Momose, T | 2 |
| Machida, K | 2 |
| Honda, N | 2 |
| Mamiya, T | 1 |
| Takahashi, T | 1 |
| Tsutsumi, K | 2 |
| Nariai, T | 3 |
| Suzuki, R | 3 |
| Hirakawa, K | 3 |
| Maehara, T | 1 |
| Ishii, K | 2 |
| Senda, M | 2 |
| Matsushima, Y | 2 |
| Ichimura, K | 1 |
| Machac, J | 1 |
| Vallabhajosula, S | 1 |
| Hoshi, H | 1 |
| Ohnishi, T | 1 |
| Jinnouchi, S | 1 |
| Futami, S | 1 |
| Nagamachi, S | 1 |
| Kodama, T | 1 |
| Watanabe, K | 1 |
| Ueda, T | 1 |
| Wakisaka, S | 1 |
| Fuse, T | 1 |
| Takagi, T | 1 |
| Touho, H | 1 |
| Karasawa, J | 1 |
| Ohnishi, H | 1 |
| Yamashita, T | 1 |
| Kashiwagi, S | 1 |
| Nakashima, K | 1 |
| Ishihara, H | 1 |
| Kitahara, T | 1 |
| Nakano, S | 1 |
| Ito, H | 1 |
| Watanabe, H | 1 |
| Ohta, S | 1 |
| Oka, Y | 1 |
| Kumon, Y | 1 |
| Sakaki, S | 1 |
| Sugawara, Y | 1 |
| Tanada, S | 1 |
| Liu, HM | 1 |
| Peng, SS | 1 |
| Li, YW | 1 |
| Mitumori, K | 1 |
1 review available for acetazolamide and Cerebrovascular Moyamoya Disease
| Article | Year |
|---|---|
Concurrent Graves' disease and intracranial arterial stenosis/occlusion: special considerations regarding the state of thyroid function, etiology, and treatment.
Topics: Acetazolamide; Adolescent; Adult; Carbonic Anhydrase Inhibitors; Cerebral Angiography; Cerebral Infa | 2011 |
1 trial available for acetazolamide and Cerebrovascular Moyamoya Disease
| Article | Year |
|---|---|
Constant-infusion H(2)15O PET and acetazolamide challenge in the assessment of cerebral perfusion status.
Topics: Acetazolamide; Adolescent; Adult; Aged; Anticonvulsants; Brain; Carotid Stenosis; Cerebrovascular Ci | 2004 |
44 other studies available for acetazolamide and Cerebrovascular Moyamoya Disease
| Article | Year |
|---|---|
Assessment of cerebral perfusion in moyamoya disease with dynamic pseudo-continuous arterial spin labeling using a variable repetition time scheme with optimized background suppression.
Topics: Acetazolamide; Adolescent; Adult; Cerebrovascular Circulation; Female; Humans; Magnetic Resonance Im | 2023 |
Assessment of cerebral perfusion in moyamoya disease with dynamic pseudo-continuous arterial spin labeling using a variable repetition time scheme with optimized background suppression.
Topics: Acetazolamide; Adolescent; Adult; Cerebrovascular Circulation; Female; Humans; Magnetic Resonance Im | 2023 |
Assessment of cerebral perfusion in moyamoya disease with dynamic pseudo-continuous arterial spin labeling using a variable repetition time scheme with optimized background suppression.
Topics: Acetazolamide; Adolescent; Adult; Cerebrovascular Circulation; Female; Humans; Magnetic Resonance Im | 2023 |
Assessment of cerebral perfusion in moyamoya disease with dynamic pseudo-continuous arterial spin labeling using a variable repetition time scheme with optimized background suppression.
Topics: Acetazolamide; Adolescent; Adult; Cerebrovascular Circulation; Female; Humans; Magnetic Resonance Im | 2023 |
Assessment of cerebral perfusion in moyamoya disease with dynamic pseudo-continuous arterial spin labeling using a variable repetition time scheme with optimized background suppression.
Topics: Acetazolamide; Adolescent; Adult; Cerebrovascular Circulation; Female; Humans; Magnetic Resonance Im | 2023 |
Assessment of cerebral perfusion in moyamoya disease with dynamic pseudo-continuous arterial spin labeling using a variable repetition time scheme with optimized background suppression.
Topics: Acetazolamide; Adolescent; Adult; Cerebrovascular Circulation; Female; Humans; Magnetic Resonance Im | 2023 |
Assessment of cerebral perfusion in moyamoya disease with dynamic pseudo-continuous arterial spin labeling using a variable repetition time scheme with optimized background suppression.
Topics: Acetazolamide; Adolescent; Adult; Cerebrovascular Circulation; Female; Humans; Magnetic Resonance Im | 2023 |
Assessment of cerebral perfusion in moyamoya disease with dynamic pseudo-continuous arterial spin labeling using a variable repetition time scheme with optimized background suppression.
Topics: Acetazolamide; Adolescent; Adult; Cerebrovascular Circulation; Female; Humans; Magnetic Resonance Im | 2023 |
Assessment of cerebral perfusion in moyamoya disease with dynamic pseudo-continuous arterial spin labeling using a variable repetition time scheme with optimized background suppression.
Topics: Acetazolamide; Adolescent; Adult; Cerebrovascular Circulation; Female; Humans; Magnetic Resonance Im | 2023 |
ASL-MRI-guided evaluation of multiple burr hole revascularization surgery in Moyamoya disease.
Topics: Acetazolamide; Adolescent; Adult; Cerebral Revascularization; Cerebrovascular Circulation; Child; Fe | 2023 |
Neuropsychological impairment in adults with moyamoya angiopathy: preoperative assessment and correlation to MRI and H
Topics: Acetazolamide; Adolescent; Adult; Aged; Cerebrovascular Circulation; Cognition Disorders; Cohort Stu | 2020 |
Paradoxical Critical Hyperkalemia After Acetazolamide for Cerebrovascular Reactivity Study: A Case Report.
Topics: Acetazolamide; Administration, Intravenous; Adult; Disease Management; Humans; Hyperkalemia; Moyamoy | 2020 |
Contralateral improvement of cerebrovascular reactivity and TIA frequency after unilateral revascularization surgery in moyamoya vasculopathy.
Topics: Acetazolamide; Cerebrovascular Circulation; Humans; Ischemic Attack, Transient; Moyamoya Disease; To | 2021 |
Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan.
Topics: Acetazolamide; Cerebrovascular Circulation; Humans; Japan; Moyamoya Disease; Off-Label Use | 2017 |
Extensive brain infarction involving deep structures during an acetazolamide-challenged single-photon emission computed tomography scan in a patient with moyamoya disease.
Topics: Acetazolamide; Anticonvulsants; Brain Infarction; Child; Female; Humans; Moyamoya Disease; Tomograph | 2017 |
Superficial temporal artery-middle cerebral artery anastomosis patency correlates with cerebrovascular reserve in adult moyamoya syndrome patients.
Topics: Acetazolamide; Adult; Anastomosis, Surgical; Female; Humans; Magnetic Resonance Imaging; Male; Middl | 2019 |
Substraction acetazolamide SPECT co-registered to MRI in moyamoya disease: quantitative cerebrovascular reserve map.
Topics: Acetazolamide; Cerebrovascular Circulation; Female; Humans; Image Processing, Computer-Assisted; Mag | 2014 |
Neovascularization precedes occlusion in moyamoya disease: angiographic findings in 172 pediatric patients.
Topics: Acetazolamide; Brain; Cardiovascular Agents; Cerebral Angiography; Cerebrovascular Circulation; Chil | 2014 |
Quantitative H2[(15)O]-PET in Pediatric Moyamoya Disease: Evaluating Perfusion before and after Cerebral Revascularization.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Cerebral Angiography; Cerebral Revascularization; Cere | 2015 |
Noninvasive method for mapping CVR in moyamoya disease using ASL-MRI.
Topics: Acetazolamide; Adolescent; Adult; Brain; Cerebrovascular Circulation; Child; Female; Humans; Iodine | 2015 |
Hemodynamic stress distribution reflects ischemic clinical symptoms of patients with moyamoya disease.
Topics: Acetazolamide; Adult; Anticonvulsants; Blood Flow Velocity; Brain; Brain Ischemia; Cerebrovascular C | 2015 |
Cerebral blood flow, transit time, and apparent diffusion coefficient in moyamoya disease before and after acetazolamide.
Topics: Acetazolamide; Adult; Blood Flow Velocity; Carbonic Anhydrase Inhibitors; Cerebral Angiography; Cere | 2017 |
Brain Perfusion Before and After Surgical Treatment of Moyamoya Disease.
Topics: Acetazolamide; Brain; Cerebrovascular Circulation; Humans; Infarction, Middle Cerebral Artery; Moyam | 2017 |
Which CT perfusion parameter best reflects cerebrovascular reserve?: correlation of acetazolamide-challenged CT perfusion with single-photon emission CT in Moyamoya patients.
Topics: Acetazolamide; Adult; Aged; Blood Flow Velocity; Blood Volume; Carbonic Anhydrase Inhibitors; Cerebr | 2008 |
Coexistence of Chiari 2 malformation and moyamoya syndrome in a 17-year-old girl.
Topics: Acetazolamide; Adolescent; Agenesis of Corpus Callosum; Anastomosis, Surgical; Arnold-Chiari Malform | 2009 |
Patient selection for revascularization procedures in adult Moyamoya disease based on dynamic perfusion computerized tomography with acetazolamide challenge (PCTA).
Topics: Acetazolamide; Adult; Cerebral Revascularization; Cerebrovascular Circulation; Female; Humans; Male; | 2010 |
Correlation between cognitive impairment and cerebral hemodynamic disturbances on perfusion magnetic resonance imaging in European adults with moyamoya disease. Clinical article.
Topics: Acetazolamide; Adult; Aged; Anticonvulsants; Cerebrovascular Circulation; Cognition Disorders; Execu | 2010 |
Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion.
Topics: Acetazolamide; Adolescent; Aphasia; Brain; Brain Edema; Cerebral Angiography; Cerebral Infarction; C | 2010 |
Ivy signs on FLAIR images before and after STA-MCA anastomosis in patients with Moyamoya disease.
Topics: Acetazolamide; Adolescent; Adult; Anastomosis, Surgical; Anticonvulsants; Cerebral Angiography; Chil | 2011 |
Contralateral cerebral hemodynamic changes after unilateral direct revascularization in patients with moyamoya disease.
Topics: Acetazolamide; Adolescent; Adult; Carotid Arteries; Cerebral Angiography; Cerebral Revascularization | 2011 |
Executive dysfunction in adults with moyamoya disease is associated with increased diffusion in frontal white matter.
Topics: Acetazolamide; Adult; Cognition Disorders; Diffusion Magnetic Resonance Imaging; Executive Function; | 2012 |
Bifrontal encephalogaleosynangiosis for children with moyamoya disease.
Topics: Acetazolamide; Adolescent; Anterior Cerebral Artery; Anticonvulsants; Brain Ischemia; Cerebral Angio | 2012 |
Analysis of ischemic cerebral lesions using 3.0-T diffusion-weighted imaging and magnetic resonance angiography after revascularization surgery for ischemic disease.
Topics: Acetazolamide; Adult; Aged; Anastomosis, Surgical; Brain; Brain Ischemia; Cerebral Revascularization | 2013 |
Hyperventilation-induced limb shaking TIA in Moyamoya disease.
Topics: Acetazolamide; Adult; Angiography; Carbonic Anhydrase Inhibitors; Carotid Stenosis; Collateral Circu | 2003 |
Metabolic changes after H(2) 15O-positron emission tomography with acetazolamide in a patient with moyamoya disease: case report and review of previous cases.
Topics: Acetazolamide; Acidosis; Adult; Blood Pressure; Carotid Arteries; Cerebral Angiography; Cerebral Rev | 2003 |
Prediction of the clinical outcome of pediatric moyamoya disease with postoperative basal/acetazolamide stress brain perfusion SPECT after revascularization surgery.
Topics: Acetazolamide; Adolescent; Anticonvulsants; Brain; Cerebral Angiography; Cerebral Revascularization; | 2005 |
Quantitative cerebrovascular reserve measured by acetazolamide-challenged dynamic CT perfusion in ischemic adult Moyamoya disease: initial experience with angiographic correlation.
Topics: Acetazolamide; Adult; Anticonvulsants; Brain Ischemia; Cerebral Angiography; Female; Humans; Male; M | 2008 |
Cerebral hemodynamics and "re-build-up" phenomenon on electroencephalogram in children with moyamoya disease.
Topics: Acetazolamide; Blood Flow Velocity; Brain; Brain Ischemia; Carotid Artery, Internal; Carotid Stenosi | 1995 |
An approach to cerebral vasodilatory capacity in unilateral and bilateral cerebrovascular diseases using radiolabeled human serum albumin.
Topics: Acetazolamide; Adolescent; Adult; Aged; Carotid Stenosis; Cerebral Infarction; Cerebrovascular Circu | 1995 |
Vascular reserve in chronic cerebral ischemia measured by the acetazolamide challenge test: comparison with positron emission tomography.
Topics: Acetazolamide; Adolescent; Adult; Aged; Blood Flow Velocity; Brain; Brain Ischemia; Cerebral Cortex; | 1995 |
Surgically induced angiogenesis to compensate for hemodynamic cerebral ischemia.
Topics: Acetazolamide; Adolescent; Adult; Brain; Cerebral Arteries; Cerebrovascular Circulation; Child; Coll | 1994 |
Cerebral vasodilatory capacity mapping using technetium-99m-DTPA-HSA SPECT and acetazolamide in moyamoya disease.
Topics: Acetazolamide; Cerebral Infarction; Cerebrovascular Circulation; Humans; Male; Middle Aged; Moyamoya | 1993 |
Cerebral versus myocardial stress perfusion imaging: role of pharmacological intervention in the diagnostic assessment of flow reserve.
Topics: Acetazolamide; Arterial Occlusive Diseases; Carbon Dioxide; Cerebrovascular Circulation; Cerebrovasc | 1994 |
Cerebral blood flow study in patients with moyamoya disease evaluated by IMP SPECT.
Topics: Acetazolamide; Adult; Amphetamines; Brain; Cerebrovascular Circulation; Contrast Media; Female; Huma | 1994 |
[Usefulness of 123I-amphetamine SPECT in evaluation of cerebral circulation by the acetazolamide test in patients with moyamoya disease].
Topics: Acetazolamide; Child; Female; Humans; Moyamoya Disease; Tomography, Emission-Computed, Single-Photon | 1993 |
Regional cerebral hemodynamics in childhood moyamoya disease.
Topics: Acetazolamide; Adolescent; Blood Flow Velocity; Brain; Cerebral Revascularization; Child; Child, Pre | 1995 |
Preoperative and postoperative evaluation of cerebral perfusion and vasodilatory capacity with 99mTc-HMPAO SPECT and acetazolamide in childhood Moyamoya disease.
Topics: Acetazolamide; Adolescent; Brain; Cerebral Angiography; Cerebrovascular Circulation; Child; Child, P | 1996 |
Xe-CT in cerebrovascular disease and moyamoya disease.
Topics: Acetazolamide; Brain; Brain Ischemia; Carbon Dioxide; Hemodynamics; Humans; Ischemic Attack, Transie | 1996 |
Modulation of cerebral hemodynamics by surgical revascularization in patients with moyamoya disease.
Topics: Acetazolamide; Adolescent; Adult; Brain; Child; Contrast Media; Female; Hemodynamics; Humans; Male; | 1996 |
Changes in cortical CBF and vascular response after vascular reconstruction in patients with adult onset moyamoya disease.
Topics: Acetazolamide; Adult; Cerebral Angiography; Cerebral Cortex; Cerebral Revascularization; Female; Hum | 1996 |
The preoperative and postoperative cerebral blood flow and vasoreactivity in childhood moyamoya disease.
Topics: Acetazolamide; Cerebrovascular Circulation; Child; Child, Preschool; Female; Humans; Infant; Male; M | 2000 |
[Cerebral blood flow reactivity to hyperventilation in children with spontaneous occlusion of the circle of willis (moyamoya disease)].
Topics: Acetazolamide; Adolescent; Cerebral Revascularization; Cerebrovascular Circulation; Child; Child, Pr | 1992 |